Review article: The pathophysiology of gastro-oesophageal reflux disease - Oesophageal manifestations

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 9, 2004, Pages 14-25

  Castell, Donald O ^a,b   Murray, J A ^c   Tutuian, R ^b   Orlando, R C ^d   Arnold, R ^e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MAYO CLINIC   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; ALCOHOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BACLOFEN; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CISAPRIDE; DIAZEPAM; DOMPERIDONE; METOCLOPRAMIDE; MORPHINE; NITRIC ACID DERIVATIVE; PANCREAS ENZYME; PEPSIN A; PETHIDINE; PROSTAGLANDIN F2 ALPHA; SEROTONIN; SILDENAFIL; THEOPHYLLINE;

ADENOCARCINOMA; ALCOHOL CONSUMPTION; BARRETT ESOPHAGUS; BILE; CACAO; CARDIOTOXICITY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; ESOPHAGUS DISEASE; ESOPHAGUS INJURY; EXPOSURE; FAT INTAKE; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; LOWER ESOPHAGUS SPHINCTER PRESSURE; NIGHT; PATHOGENESIS; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; RISK FACTOR; SIDE EFFECT; SMOKING; STOMACH DISTENSION; STOMACH EMPTYING; SUPINE POSITION; SYSTEMATIC REVIEW;

EID: 10644282117     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02238.x     Document Type: Review

References (96)

1. Kahrilas PJ. GERD pathogenesis, pathophysiology, and clinical manifestations. Cleve Clin J Med 2003; 70(Suppl. 5): S4-19.
2. Dent J, Dodds WJ, Friedman RH, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980; 65: 256-67.
3. Kahrilas PJ. Gastroesophageal reflux disease and its complications. In: Feldman M, Sleisenger MH, Scharschmidt BF, eds. Sleisinger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. Philadelphia, PA: W.B. Saunders Company, 1998: 498-517.
4. DeMeester TR, Johnson LF, Joseph GJ, Toscano MS, Hall AW, Skinner DB. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976; 184: 459-70.
5. Mittal RK, Lange RC, McCallum RW. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology 1987; 92: 130-5.
6. Holloway RH, Kongo M, Berger K, McCallum RW. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology 1985; 89: 779-84.
7. Orlando RC. Pathophysiology of gastroesophageal reflux disease: offensive factors and tissue resistance. In: Orlando RC, ed. Gastroesophageal Reflux Disease. New York: Marcel Dekker, 2000: 165-92.
8. Mittal RK, Balaban DH. Mechanisms of disease: the esophagogastric junction. N Engl J Med 1997; 336: 924-32.
9. Pandolfino JE, Shi G, Trueworthy B, Kahrilas PJ. Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects. Gastroenterology 2003; 125: 1018-24.
10. Hill LD, Kozarek RA, Kraemer SJ, et al. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc 1996; 44: 541-7.
11. Mittal RK, Rochester DF, McCallum RW, Effect of the diaphragmatic contraction on lower oesophageal sphincter pressure in man. Gut 1987; 28: 1564-8.
12. Mittal RK, Fisher M, McCallum RW, Rochester DF, Dent J, Sluss J. Human lower esophageal sphincter pressure response to increased intra-abdominal pressure. Am J Physiol 1990; 258: G624-G30.
13. Babka JC, Hager GW, Castell DO. The effect of body position on lower esophageal sphincter pressure. Am J Dig Dis 1973; 18: 441-2.
14. Sears VW Jr, Castell JA, Castell DO. Comparison of effects of upright versus supine body position and liquid versus solid bolus on esophageal pressures in normal humans. Dig Dis Sci 1990; 35: 857-64.
15. Iwakiri K, Sugiura T, Kotoyori M, et al. Effect of body position on lower esophageal sphincter pressure. J Gastroenterol 1999; 34: 305-9.
16. Nebel OT, Castell DO. Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology 1972; 63: 778-83.
17. Nebel OT, Castell DO. Inhibition of the lower oesophageal sphincter by fat-a mechanism for fatty food intolerance. Gut 1973; 14: 270-4.
18. Dennish GW, Castell DO. Inhibitory effect of smoking on the lower esophageal sphincter. N Engl J Med 1971; 284: 1136-7.
19. Pehl C, Pfeiffer A, Wendl B, Kaess H, Different effects of white and red wine on lower esophageal sphincter pressure and gastroesophageal reflux. Scand J Gastroenterol 1998; 33: 118-22.
20. Wright LE, Castell DO. The adverse effect of chocolate on lower esophageal sphincter pressure. Am J Dig Dis 1975; 20: 703-7.
21. Dennish GW, Castell DO. Caffeine and the lower esophageal sphincter, Am J Dig Dis 1972; 17: 993-6.
22. Castell DO, Harris LD. Hormonal control of gastroesophageal-sphincter strength. N Engl J Med 1970; 282: 886-9.
23. Katz PO. Medical management of GERD. In: Castell DO, Richter JE. eds. The Esophagus. Philadelphia: Lippincott Williams & Wilkins. 2004: 460-79.
24. Allescher HD. Stoschus B. Wunsch E, Schusdziarra V. Classen M. Effect of human gastrin-17 with and without acid suppression on human esophageal motility. Z Gastroenterol 1995; 33: 385-91.
25. Higgs RH, Humphries TJ, Castell DO. McGuigan JE. Lower esophageal sphincter pressures and serum gastrin levels after cholinergic stimulation. Am J Physiol 1976; 231: 1250-3.
26. Castell DO. Changes in lower esophageal sphincter pressure during insulin-induced hypoglycemia. Gastroenterology 1971; 61: 10-5.
27. Corazziari E, Delle FG, Pozzessere C, et al. Effect of bombesin on lower esophageal sphincter pressure in humans. Gastroenterology 1982; 83: 10-4.
28. Fisher RS, DiMarino AJ, Cohen S. Mechanism of cholecystokinin inhibition of lower esophageal sphincter pressure. Am J Physiol 1975; 228: 1469-73.
29. Bainbridge ET, Nicholas SD, Newton JR, Temple JG. Gastrooesophageal reflux in pregnancy. Altered function of the barrier to reflux in asymptomatic women during early pregnancy. Scand J Gastroenterol 1984; 19: 85-9.
30. Hey VM, Cowley DJ, Ganguli PC, Skinner LD, Ostick DG, Sharp DS. Gastro-oesophageal reflux in late pregnancy. Anaesthesia 1977; 32: 372-7.
31. Nelson JL III, Richter JE, Johns DN, Castell DO, Centola GM. Esophageal contraction pressures are not affected by normal menstrual cycles. Gastroenterology 1984; 87: 867-71.
32. Alvarez-Sanchez A, Rey E, Achem SR, Diaz-Rubio M. Does progesterone fluctuation across the menstrual cycle predispose to gastroesophageal reflux? Am J Gastroenterol 1999; 94: 1468-71.
33. Kahrilas PJ, Lin S, Chen J, Manka M. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut 1999; 44: 476-82.
34. Pandolfino JE, Shi G, Curry J, Joehl RJ, Brasseur JG, Kahrilas PJ. Esophagogastric junction distensibility: a factor contributing to sphincter incompetence. Am J Physiol Gastrointest Liver Physiol 2002; 282: G1052-8.
35. Fisher RS, Malmud LS, Roberts GS, Lobis IF. The lower esophageal sphincter as a barrier to gastroesophageal reflux. Gastroenterology 1977; 72: 19-22.
36. Fein M, Ritter MP, DeMeester TR, et al. Role of the lower esophageal sphincter and hiatal hernia in the pathogenesis of gastroesophageal reflux disease. J Gastrointest Surg 1999; 3: 405-10.
37. Kraus BB, Wu WC, Castell DO. Comparison of lower esophageal sphincter manometrics and gastroesophageal reflux measured by 24-hour pH recording. Am J Gastroenterol 1990; 85: 692-6.
38. DeMeester TR, Wernly JA, Bryant GH, Little AG, Skinner DB. Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of the principles of antireflux surgery. Am J Surg 1979; 137: 39-46.
39. Schoeman MN, Tippett MD, Akkermans LM, Dent J, Holloway RH. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 1995; 108: 83-91.
40. Mittal RK, McCallum RW. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology 1988; 95: 593-9.
41. Penagini R, Schoeman MN, Dent J, Tippett MD, Holloway RH. Motor events underlying gastro-oesophageal reflux in ambulant patients with reflux oesophagitis. Neurogastroenterol Motil 1996; 8: 131-41.
42. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982; 307: 1547-52.
43. Hornby PJ, Abrahams TP. Central control of lower esophageal sphincter relaxation. Am J Med 2000; 108(Suppl. 4a): S90-S8.
44. Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology 2000; 118: 688-95.
45. Scheffer RC, Akkermans LM, Bais JE, Roelofs JM, Smout AJ, Gooszen HG. Elicitation of transient lower oesophageal sphincter relaxations in response to gastric distension and meal ingestion. Neurogastroenterol Motil 2002; 14: 647-55.
46. Boulant J, Mathieu S, D'Amato M, Abergel A, Dapoigny M, Bommelaer G. Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans. Gut 1997; 40: 575-81.
47. Penagini R, Carmagnola S, Cantu P, Allocca M, Bianchi PA. Mechanoreceptors of the proximal stomach: Role in triggering transient lower esophageal sphincter relaxation. Gastroenterology 2004; 126: 49-56.
48. Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABA (B) agonist baclofen in normal subjects. Gastroenterology 2000; 118: 7-13.
49. Browning KN, Travagli RA, Mechanism of action of baclofen in rat dorsal motor nucleus of the vagus. Am J Physiol Gastrointest Liver Physiol 2001; 280: G1106-13.
50. Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003; 17: 243-51.
51. van Herwaarden MA, Samsom M, Rydholm H, Smout AJ. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Ther 2002; 16: 1655-62.
52. Wright RA, Hurwitz AL. Relationship of hiatal hernia to endoscopically proved reflux esophagitis. Dig Dis Sci 1979; 24: 311-3.
53. Ott DJ, Gelfand DW, Chen YM, Wu WC, Munitz HA. Predictive relationship of hiatal hernia to reflux esophagitis. Gastrointest Radiol 1985: 10: 317-20.
54. Jones MP, Sloan SS, Rabine JC, Ebert CC, Huang CF, Kahrilas PJ. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 1711-7.
55. Cameron AJ. Barren's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 1999; 94: 2054-9.
56. Sloan S, Rademaker AW, Kahrilas PJ. Determinants of gastroesophageal junction incompetence: hiatal hernia, lower esophageal sphincter, or both? Ann Intern Med 1992; 117: 977-82.
57. Sloan S, Kahrilas PJ. Impairment of esophageal emptying with hiatal hernia. Gastroenterology 1991; 100: 596-605.
58. Schwizer W, Hinder RA, DeMeester TR. Does delayed gastric emptying contribute to gastroesophageal reflux disease? Am J Surg 1989; 157: 74-81.
59. Shay SS, Eggli D, McDonald C, Johnson LF. Gastric emptying of solid food in patients with gastroesophageal reflux. Gastroenterology 1987; 92: 459-65.
60. McCallum RW, Berkowitz DM, Lerner E. Gastric emptying in patients with gastroesophageal reflux. Gastroenterology 1981; 80: 285-91.
61. Buckles DC, Sarosiek I, McMillin C, McCallum RW. Delayed gastric emptying in gastroesophageal reflux disease: reassessment with new methods and symptomatic correlations. Am J Med Sci 2004; 327: 1-4.
62. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995; 37: 7-12.
63. Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457-64.
64. Rodriguez-Stanley S, Robinson M, Earnest DL. Greenwood-Van Meerveld B. Miner PB Jr. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 1999; 94: 628-31.
65. Kern MK, Birn RM, Jaradeh S, et al. Identification and characterization of cerebral cortical response to esophageal mucosal acid exposure and distention. Gastroenterology 1998; 115: 1353-62.
66. Watson RG, Tham TC, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux-the 'sensitive oesophagus'. Gut 1997; 40: 587-90.
67. Bell RC, Hanna P, Brubaker S, Laparoscopic fundoplication for symptomatic but physiologic gastroesophageal reflux. J Gastrointest Surg 2001; 5: 462-7.
68. Orlando RC. Reflux esophagitis. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE. eds. Textbook of Gastroenterology. Philadelphia: JB Lippincott. 1991: 1123.
69. Schlesinger PK, Donahue PE, Schmid B, Layden TJ. Limitations of 24-hour intraesophageal pH monitoring in the hospital setting. Gastroenterology 1985; 89: 797-804.
70. Bernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology 1958; 34: 760-81.
71. Dixon J, Strugala V, Griffin SM, et al. Esophageal mucin: an adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barren's esophagus. Am J Gastroenterol 2001; 96: 2575-83.
72. Quigley EM, Turnberg LA. pH of the microclimate lining human gastric and duodenal mucosa in vivo. Studies in control subjects and in duodenal ulcer patients. Gastroenterology 1987; 92: 3876-84.
73. Tobey NA, Hosseini SS, Caymaz-Bor C, Wyatt HR, Orlando GS, Orlando RC. The role of pepsin in acid injury to esophageal epithelium. Am J Gastroenterol 2001; 96: 3062-70.
74. 3- transport systems. Am J Physiol 1992; 263: G407-13.
75. Tobey NA, Reddy SP, Khalbuss WE, Silvers SM, Cragoe EJ Jr, Orlando RC. Na(+)-dependent and -independent CI-/HC03-exchangers in cultured rabbit esophageal epithelial cells. Gastroenterology 1993; 104: 185-95.
76. Bass BL, Schweitzer EJ, Harmon JW, Kraimer J. H+ back diffusion interferes with intrinsic reactive regulation of esophageal mucosal blood Mow. Surgery 1984; 96: 404-13.
77. Bor S, Bor-Caymaz C, Tobey NA, Abdulnour-Nakhoul S, Orlando RC. Esophagcal exposure to ethanol increases risk of acid damage in rabbit esophagus. Dig Dis Sci 1999; 44: 290-300.
78. Long JD, Marten E, Tobey NA, Orlando RC. Luminal hypertonicity and the susceptibility of rabbit esophagus to acid injury. Dis Esophagus 1998; 11: 94-100.
79. Orlando RC, Bryson JC, Powell DW. Effect of cigarette smoke on esophageal epithelium of the rabbit. Gastroenterology 1986; 91: 1536-42.
80. Tobey NA, Sikka D, Marten E, Caymaz-Bor C, Hosseini SS. Orlando RC. Effect of heat stress on rabbit esophageal epithelium. Am J Physiol 1999; 276: G1322-30.
81. Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol 2004; 99: 13-22.
82. Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology 1996; 111: 1200-5.
83. Solcia E, Villani L, Luinetti O, et al. Altered intercellular glycoconjugates and dilated intercellular spaces of esophageal epithelium in reflux disease. Virchows Arch 2000; 436: 207-16.
84. Rodrigo J, Hernandez CJ, Vidai MA, Pedrosa JA. Vegetative innervation of the esophagus. III. Intraepithelial endings. Acta Anat (Basel) 1975; 92: 242-58.
85. Rourk RM, Namiot Z, Edmunds MC, Sarosiek J, Yu Z, McCallum RW. Diminished luminal release of esophageal epidermal growth factor in patients with reflux esophagitis. Am J Gastroenterol 1994; 89: 1177-84.
86. Ismail-Beigi F, Horton PF, Pope CE, Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58: 163-74.
87. Long JD, Marten E, Tobey NA, Orlando RC. Effects of luminal hypertonicity on rabbit esophageal epithelium. Am J Physiol 1997; 273: G647-54.
88. Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR III. Pedersen NL. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2002; 122: 55-9.
89. Romero Y, Cameron AJ, Locke GR III, et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 1997; 113: 1449-56.
90. Orr WC, Robinson MG, Johnson LF. Acid clearance during sleep in the pathogenesis of reflux esophagitis. Dig Dis Sci 1981; 26: 423-7.
91. Robertson D, Aldersley M, Shepherd H, Smith CL. Patterns of acid reflux in complicated oesophagitis. Gut 1987; 28: 1484-8.
92. Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Mason RJ. The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease. Arch Surg 1999; 134: 882-7.
93. Orr WC, Eisenbruch S, Harnish MJ, Johnson LF, Proximal migration of esophageal acid perfusions during waking and sleep. Am J Gastroenterol 2000; 95: 37-42.
94. Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 1978; 64: 564-8.
95. Jacob P, Kahrilas PJ, Herzon G. Proximal esophageal pH-metry in patients with 'reflux laryngitis'. Gastroenterology 1991; 100: 305-10.
96. Shaker R, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 1995; 109: 1575-82.